Company
Overview
Our Commitment
Core Values
Executive Leadership
Services
Discovery & Preclinical
Pharmacology Services
Drug Safety Assessment
General Toxicology
Safety Pharmacology
Genetic Toxicology
Early Clinical Research (Phase I – IIa)
Phase I-IIa
Bioequivalence Studies
Pharmacokinetics / Pharmacodynamics
Global Clinical Development (Phase II-IV)
Development and Regulatory Services
Feasibility Research
Investigator and Patient Recruitment
Project Management and Clinical Monitoring
Medical Affairs and Safety Management
Central Lab & Centralized Cardiac Services
Data Management
Biostatistics
Medical and Scientific Writing
Quality Assurance
Connecting your trials to global regions
Bioanalysis
Small Molecule Bioanalysis
Large Molecule Bioanalysis
Validated Assays
Global Central Lab
Global Services
Centralized Cardiac Services
ECG Devices
ECG Locations
Quality Assurance
Development & Regulatory Services
Drug Development
Biopharmaceutical Development
Regulatory Affairs
Program Management
Quality Assurance Services
Cardiac Safety Center of Excellence
Therapeutic Experience
List A-Z
List by Location
Locations
All Locations
Executive Offices
Discovery & Preclinical
Early Clinical Research
Global Clinical Development (Phase II-IV)
Bioanalysis
Global Central Lab
Scientific Library
Posters
Presentations
Podcasts
Webinars
Case Studies
White Papers
Events
News
News Releases
Media Coverage
Contact Us
Study Participation
Medical Investigators
Careers at MDS
Investors
MDS Pharma Services News
April 8, 2009
MDS Pharma Services Appoints Dr. Ping Li as Laboratory Director for Beijing Central Lab
March 11, 2009
MDS Pharma Services Scientist Named to List of ‘Notable People in R&D’ for 2009
February 12, 2009
An Open Letter to Clients from President David Spaight
February 12, 2009
MDS Pharma Services Scientist to Discuss Development of Biosimilar Monoclonal Antibodies at EGA Symposium
January 26, 2009
MDS Pharma Services Scientific Experts to Join FDA and NIH on Biomarker Panel
More news from MDS Inc.
Home
/
Study Participation
/
Current Studies
Current Studies in
Neptune, New Jersey
Spare Time???
YOU CAN MAKE A DIFFERENCE BY ASSISTING MEDICAL RESEARCH
The study medication is Clopidgrel indicated for the reduction of further heart attacks
Men
18-45 years of age
Nonsmokers for at least six months
Available for one 5 day/night stay and one outpatient visit
Compensation will total upon completion $2935.00
For more information, fill out the online
Study Participation Application
!
Spare Time???
YOU CAN MAKE A DIFFERENCE BY ASSISTING MEDICAL RESEARCH
The medication is an investigational medication being developed in order to provide a more effective treatment for inflammatory bowel syndrome
Male/Female
18-45 years of age
Nonsmokers for at least two months
Available for a 16 day/night stay, one outpatient visit and one follow-up phone call
Compensation will total upon completion $2840.00
For more information, fill out the online
Study Participation Application
!
© 2009 MDS Pharma Services |
Corporate Governance
|
Legal
|
Privacy
|
Site Map
